Last reviewed · How we verify

NCT03390127

Effect of PEEP on Arterial Oxygen Partial Pressure in Elderly Patients With Lithotomy Position Using LMA Supreme™

Completed NA Last updated 6 April 2018
What this trial tests

NA trial testing PEEP in Urinary Bladder Neoplasms in 68 participants. Completed in 21 March 2018.

Timeline
5 January 2018
Primary endpoint
14 March 2018
21 March 2018

Quick facts

Lead sponsorAsan Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposesupportive care
Enrollment68
Start date5 January 2018
Primary completion14 March 2018
Estimated completion21 March 2018
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Asan Medical Center

Who can join

Adults 65 to 79, any sex, with Urinary Bladder Neoplasms or Prostatic Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the present study is to compare the effect of PEEP on arterial oxygen partial pressure in elderly patients undergoing urologic surgery using LMA supreme™ in a lithotomy position.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of PEEP

Trials testing the same drug.

Other recruiting trials for Urinary Bladder Neoplasms

Currently open trials in the same condition.

Other Asan Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03390127.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing